Chiefs receiver Rashee Rice is officially back from his suspension this week, and he’s practicing on Wednesday as Kansas City gets set to play Las Vegas. Rice has not played since suffering a ...

What if you could turn a single static image into a polished, 30-second commercial, all without hiring a production team or spending hours on editing software? Thanks to the rise of AI-powered ...

Diego is a writer and editor with over six years of experience covering games. He's mainly focused on guides, but he's done reviews, features, news, and everything in between. A fan of all genres, you ...

Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. As Halloween draws near, images of burials gone wrong can easily ...

Cash used to be king. Now, many of us find it bizarre when someone pays with a Jackson or, in an even more rare sight, pulls out a checkbook. The U.S. began its march to a cashless payment system more ...

Earlier this year, Apple introduced its Foundation Models framework during WWDC 2025, which allows developers to use the company’s local AI models to power features in their applications. The company ...

We are all about getting the most out of our wardrobes. Sure, you may be fully embracing your beloved snuggly jumpers and knee-high boots right now, but before you dive headfirst into a pile of plaid ...

On Tuesday, OpenAI announced Sora 2, its second-generation video-synthesis AI model that can now generate videos in various styles with synchronized dialogue and sound effects, which is a first for ...

Though moviegoers certainly have an appetite for franchise slop these days, it’s a stretch to say that they’d be willing to bite down on wholly AI-generated movies just yet. Even more of a stretch: ...

Ben Khalesi covers the intersection of artificial intelligence and everyday tech at Android Police. With a background in AI and data science, he enjoys making technical topics approachable for those ...

VectorY Therapeutics has seen the shape of things to come—and it involves finding fresh ways to deliver its gene therapies into the brain. The Dutch biotech has secured an exclusive option to evaluate ...